HF
ARCT icon

HRT Financial’s Arcturus Therapeutics ARCT Stock Holding History

HRT Financial’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,129
Closed -$116K – 4132
2026
Q1 		$116K Buy
+15,129
New +$110K ﹤0.01% 3321
2025
Q4 		– Sell
-124,989
Closed -$2.3M – 3142
2025
Q3 		$2.3M Buy
+124,989
New +$2.01M 0.01% 1067
2024
Q3 		– Sell
-11,147
Closed -$271K – 2379
2024
Q2 		$271K Buy
+11,147
New +$338K ﹤0.01% 1539
2024
Q1 		– Sell
-18,966
Closed -$597K – 2277
2023
Q4 		$597K Buy
+18,966
New +$451K ﹤0.01% 1271
2023
Q3 		– Sell
-23,377
Closed -$670K – 2372
2023
Q2 		$670K Sell
23,377
-59,628
-72% -$1.62M 0.01% 1194
2023
Q1 		$1.99M Buy
83,005
+22,523
+37% +$404K 0.02% 598
2022
Q4 		$1.02M Buy
+60,482
New +$1.05M 0.01% 948
2021
Q4 		– Sell
-12,708
Closed -$607K – 3140
2021
Q3 		$607K Buy
+12,708
New +$569K ﹤0.01% 1807

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

HRT Financial's ARCT Position: Q2 2026 in Review

HRT Financial sold out of Arcturus Therapeutics (ARCT) in Q2 2026, closing a stake of 15,129 shares — an estimated $116K sold.

HRT Financial first reported a position in ARCT in Q3 2021 and held it in 8 quarters. The position peaked at $2.3M in Q3 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • HRT Financial reported no remaining Arcturus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 15,129 Arcturus Therapeutics shares in Q2 2026, an estimated $116K.
  • HRT Financial first reported a position in Arcturus Therapeutics in Q3 2021 and held it in 8 quarters.
  • HRT Financial's Arcturus Therapeutics position peaked at $2.3M in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.